Previous studies have shown that EZH2 silencing reduced cancer cell growth, migration and invasion in SCCHN (Liu et al., 2013; Chang et al., 2016), but which lack transgenic animal experiments and does not involve the influence of EZH2 on tumor microenvironment regulation of tumor genesis and development. Here, EZH2 is linked to head and neck squamous cell carcinoma.